|
Indonesia Wants To End Vaccinating
Children Citing Mistrust of Drug Companies
Indonesia's controversial health minister says she wants to end
vaccinating children against meningitis, mumps and some other diseases
because she fears foreign drug companies are using the country as
a testing ground.
Health Minister Siti Fadillah Supari — who first drew widespread
attention by boycotting the World Health Organization's 50-year-old
virus sharing system in 2007 — said Tuesday she wanted "scientific
proof" that shots for illnesses like pneumonia, chicken pox, the
flu, rubella and typhoid were "beneficial".
"If not, they have to be stopped," she said, declining to say
exactly what that would mean. "We don't want our country to be
a testing place for drugs, as has been the case in Africa."
Supari said she still would advocate immunizations against measles,
polio, tetanus, hepatitis B and tuberculosis.
Her statement comes at a time when Indonesia is struggling to
contain outbreaks of preventable childhood illnesses.
Chronic funding problems and chaotic decentralization efforts
since the 1998 ouster of longtime dictator Suharto have forced
many local clinics in the poorest parts of the nation to scale
back operations, reducing the time and money spent on education
and routine immunizations.
The number of cases of measles, tuberculosis and other diseases
has skyrocketed. Polio briefly re-emerged after a decade-long
absence in 2005.
The U.N. children's agency said it would wait until the country
officially changes its immunization policy before commenting.
"We are continuing to support the government as technical partners
in their implementation of the evidence-based programs," said
Anne Vincent at UNICEF.
Indonesia's health minister is no stranger to controversy —
or conspiracy theories.
When she stopped sharing bird flu viruses with the international
community two years ago she argued, among other things, that the
U.S. government could use the samples to create a biological weapon.
In November, she issued a decree banning foreign drug makers from
selling products in Indonesia unless they build local production
facilities.
|